Stable isotope methods for high-precision proteomics.

Target Discovery Inc., 4015 Fabian Way, Palo Alto, CA 94303, USA.
Drug Discovery Today (Impact Factor: 5.96). 04/2005; 10(5):353-63. DOI: 10.1016/S1359-6446(05)03381-7
Source: PubMed

ABSTRACT Stable isotope tagging methods provide a useful means of determining the relative expression level of individual proteins between samples in a mass spectrometer with high precision (coefficients of variation less than 10%). Because two or more samples tagged with different numbers of stable isotopes can be mixed before any processing steps, sample-to-sample recovery differences are eliminated. Mass spectrometry also allows post-translational modifications, splice variations and mutations (often unnoticed in immunoassays) to be detected and identified, increasing the clinical relevance of the assay and avoiding the issues of non-specific binding and cross-reactivity observed in immunoassays. Several stable isotope tagging methods are available for use in proteomics research. We discuss the advantages and disadvantages of each technique with respect to biomarker discovery, target validation, efficacy and toxicology screening and clinical diagnostic applications.

Download full-text


Available from: Luke V Schneider, Jun 13, 2014
1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Over the past decade, proteomics has undergone a rapid development and radiation, diversifying across the biochemical landscape. While no single technique yet delivers complete proteomic coverage, application-specific adaptations afford significant opportunity for discovery and the development of predictive capacity (e.g. surrogate biomarker and clinical diagnostics). Targeted proteomic approaches, protein profiling strategies using affinity capture mass spectrometry and solution array represent realistic opportunities to deliver predictive capacity. The aim of this review is to provide an overview of proteomic technologies and how the outcomes delivered by such platforms may be translated into applications of predictive utility in clinical and basic science. In particular, recent applications in protein/peptide profiling (solid-phase affinity capture mass spectrometry and the targeted approach of antibody arrays) and the opportunities they afford researchers within the discipline of reproductive biology to develop new diagnostic and prognostic tests and surrogate biomarkers to improve the delivery of women's health care are considered.
    Placenta 05/2006; 27 Suppl A:S76-86. DOI:10.1016/j.placenta.2005.11.003
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Genomic and proteomic based global gene expression profiling has altered the landscape of biological research in the past few years. Its potential impact on cell culture bioprocessing has only begun to emanate, partly due to the lack of genomic sequence information for the most widely used industrial cells, Chinese hamster ovary (CHO) cells. Transcriptome and proteome profiling work for species lacking extensive genomic resources must rely on information for other related species or on data obtained from expressed sequence tag (EST) sequencing projects, for which burgeoning efforts have only recently begun. This article discusses the aspects of EST sequencing in those industrially important, genomic resources-poor cell lines, articulates some of the unique features in employing microarray in the study of cultured cells, and highlights the infrastructural needs in establishing a platform for genomics based cell culture research. Recent experience has revealed that generally, most changes in culture conditions only elicit a moderate level of alteration in gene expression. Nevertheless, by broadening the conventional scope of microarray analysis to consider estimated levels of transcript abundance, much physiological insight can be gained. Examples of the application of microarray in cell culture are discussed, and the utility of pattern identification and process diagnosis are highlighted. As genomic resources continue to expand, the power of genomic tools in cell culture processing research will be amply evident. The key to harnessing the immense benefit of these genomic resources resides in the development of physiological understanding from their application.
    Cytotechnology 04/2006; 50(1-3):121-40. DOI:10.1007/s10616-006-9004-9
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The losses and parasitics associated with MMIC technology prevent the realization of high-Q passive components, a necessity for highly-selective low-loss filters. For applications such as communications and radar, passive filters are preferred over active filters due to the latter's issues with linearity and stability. This paper investigates the value of using highly-selective but lossy filters implemented using low-Q components. It is shown that equivalent system performance can be achieved with such a filter using a modified receiver architecture. A simplified lossy design technique using resistive-compensating networks is also presented.
    Microwave Symposium Digest, 2004 IEEE MTT-S International; 07/2004